Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001934395 | SCV002208399 | uncertain significance | 2-aminoadipic 2-oxoadipic aciduria | 2023-02-01 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. ClinVar contains an entry for this variant (Variation ID: 1438963). This variant has been observed in individual(s) with clinical features of 2-aminoadipic 2-oxoadipic aciduria (PMID: 28454995). This variant is present in population databases (rs754298961, gnomAD 0.06%). This sequence change falls in intron 14 of the DHTKD1 gene. It does not directly change the encoded amino acid sequence of the DHTKD1 protein. It affects a nucleotide within the consensus splice site. |
Ambry Genetics | RCV002562177 | SCV003620398 | uncertain significance | Inborn genetic diseases | 2022-06-10 | criteria provided, single submitter | clinical testing | The c.2402+3A>G intronic alteration consists of a A to G substitution 3 nucleotides after exon 14 of the DHTKD1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |